Daulat, Avais M.
Finetti, Pascal
Revinski, Diego
Silveira Wagner, Mônica
Camoin, Luc
Audebert, Stéphane
Birnbaum, Daniel
Kodjabachian, Laurent
Borg, Jean-Paul
Bertucci, François
Funding for this research was provided by:
La Ligue Nationale Contre le Cancer SIRIC INCa-DGOS-Inserm 6038
INCA PLBIO INCa 9474
Science without Borders PhD program from Brazil Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).
Institut Paoli-Calmettes (IPC) Canceropôle PACA
La Ligue Nationale Contre le Cancer
La Ligue Nationale Contre le Cancer (Label Ligue) Fondation ARC pour la Recherche sur le Cancer Scholar of Institut Universitaire de France
Fondation ARC pour la Recherche sur le Cancer
Article History
Received: 6 December 2018
Revised: 8 March 2019
Accepted: 18 March 2019
First Online: 11 April 2019
Competing interests
: The authors declare no competing interests.
: Samples of human origin and associated data were obtained from the IPC/CRCM Tumour Bank that operates under authorisation # AC-2013–1905 granted by the French Ministry of Research. Prior to sample storing, patients had been appropriately informed and had provided written informed consent, in compliance with French and European regulations. The project was approved by our Institutional Review Board. The study was performed in accordance with the Declaration of Helsinki. All <i>Xenopus</i> experiments were performed following the Directive 2010/63/EU of the European parliament and of the council of 22 September 2010 on the protection of animals used for scientific purposes. Experiments on <i>Xenopus laevis</i> were approved by the “Direction départementale de la Protection des Populations, Pôle Alimentation, Santé Animale, Environnement, des Bouches du Rhône” (agreement number F 13 055 21).
: The mass spectrometry proteomics data, including search results, will be deposited to the ProteomeXchange Consortium (ExternalRef removed)<sup>42</sup> via the PRIDE partner repository with the data set identifier PXD011253.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).